Delivery Order SPE2DB22D1017-SPE2DB24FG2YH

Award Date 8/9/24
Potential Completion Date 8/12/24
Potential Value $1.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,501.50, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for a Delivery Order contract to supply TRULICITY 3 MG/0.5 ML PEN 0.5ML, a medication used to treat diabetes. The contract has a Firm Fixed Price pricing type and an ultimate completion date of June 4, 2025. This award is not associated with a set-aside program and is part of a...
This federal contract award, valued at $3,757.48, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a medication used for diabetes management. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of TRULICITY 3 MG/0.5 ML PEN 0.5ML, a prescription medication. The fixed-price delivery order, valued at $2,112.18, has a completion date of September 12, 2024. Amerisourcebergen, through its Corporate Office Division, has been awarded this contract to supply the specified pharmaceutical product to support federal healthcare programs...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $7,931.43 firm fixed price delivery order is for the supply of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a prescription medication. This award is a part of Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,741.68 contract is for the supply of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML, a diabetes medication. The award has a firm fixed price pricing type and an ultimate completion date of March 28, 2023. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) worth $999,999,999 with the DLA Troop Support Medical, which serves...
This federal contract award, valued at $1,801.80, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of TRULICITY 4.5 MG/0.5 ML PEN 0.5ML, a diabetes medication. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of May 14, 2025. This award is not associated with a set-aside program, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
This federal contract award of $1,741.68 was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of TRULICITY 3 MG/0.5 ML PEN 0.5ML. The contract has a firm fixed price pricing type and an ultimate completion date of June 28, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This federal contract award, valued at $1,741.68, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order under DLA's Indefinite Delivery Contract (IDC) worth up to $999,999,999, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This particular delivery order is for TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a medication used...
This federal contract award, valued at $40,075.37, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML medical supplies, with a completion date of September 27, 2024. This is a delivery order contract with a firm fixed price pricing type. Amerisourcebergen Drug Corp's Corporate Office Division is the awardee, and the contract does not have a set-aside...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,741.68 Delivery Order contract is for the supply of TRULICITY 3 MG/0.5 ML PEN 0.5ML, a prescription medication. The award has a firm fixed price and an ultimate completion date of August 30, 2024. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with DLA Troop Support Medical and the Department of Justice Federal Bureau of...
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB24FG2YH
    Delivery Order

This federal contract award, valued at $1,552.38, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order for the supply of TRULICITY 3 MG/0.5 ML PEN 0.8ML, a diabetes medication. The contract has an ultimate completion date of August 12, 2024 and is a firm fixed-price arrangement. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp's Corporate Office Division holds several notable Indefinite Delivery Contracts (IDCs) with the DLA and Department of Justice Federal Bureau of Investigation, valued at up to $999,999,999 and $750,000 respectively, for providing a wide range of pharmaceutical and medical supplies to support federal healthcare programs and facilities.

Generated 11/8/24, 9:02 AM